Transforming Molecular Diagnostics

Rapid Detection of Infectious Diseases

Rapid and comprehensive detection of pathogens is an important strategy in reducing the spread of infectious disease. Our EasyScreen™ Detection Kits identify a larger number of pathogen targets in a shorter time frame than conventional methods.

Efficient Workflow

Traditional techniques for identifying viral, bacterial and protozoan pathogens require a high degree of knowledge and can take days to get a result. Our EasyScreen™ Detection Kits replace these methodologies with a single efficient workflow that requires less training, staff and hands-on-time, and gives a result in under 5 hours.

Automatable

The Genetic Signatures GS1 platform is a high-throughput bench top platform that performs both nucleic acid extraction and automated 384-well PCR set-up for the entire EasyScreen™ range. Our EasyScreen™ Detection Kits are also compatible with most existing automated nucleic acid extraction and real-time PCR instruments.

Standardised Sample Processing

Our EasyScreen™ Sample Processing Kits offer streamlined preparation of nucleic acids direct from the primary specimen. Our sample processing method is common for all specimen types leading to workflow efficiencies and standardised results between laboratories.

3Base™ Multiplex Technology

Our 3Base™ technology forms the basis of the EasyScreen™ Detection Kits. 3Base™ allows for simpler design of molecular assays facilitating the simultaneous detection of multiple targets. 3base™ is compatible with both RNA and DNA targets.

Product Pipeline

Genetic Signatures has a number of new detection kits in development. All new products follow a defined development and commercialisation process comprised of (i) Experimental Analytical Validation, and (ii) Clinical and Regulatory Validation prior to release.

Latest News

Global, multibillion-dollar fight against superbugs: “Drs should be encouraged to use Diagnostic Tests”

| Latest News | No Comments

19 May 2016 – The Age: Superbugs will kill 10 million people a year by 2050 This recent article published in The Age describes a call to action from Britain’s chancellor,…

Genetic Signatures CSO presents on the development of an EasyScreen™ assay for the detection of Extended Spectrum Beta-Lactamase (ESBL) and Carbapenemase Producing Organisms (CPO)

| Latest News | No Comments

Dr. Doug Millar, Genetic Signatures Chief Scientific Officer, presented a scientific poster titled “A Rapid 3base™ Real-Time PCR for the detection of Extended Spectrum Beta-Lactamase and Carbapenemase Producing Organisms using…

See Genetic Signatures at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

| Latest News | No Comments

Molecular diagnostics (MDx) company Genetic Signatures is attending the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), to be held on 9-12 April 2016 in Amsterdam, Netherlands. Dr…

Genetic Signatures EasyScreen™ Pathogen Detection Kit Performance Highlighted at Recent Molecular Microbiology Conference

| Latest News | No Comments

Two scientific presentations given at the recent 5th Molecular Microbiology Meeting in Sydney, Australia have described the superior performance of Genetic Signatures EasyScreen™ Pathogen Detection Kits. The first presentation titled…